title: In adults with reduced left ventricular ejection fractions (systolic heart failure), does coenzyme Q10 improve cardiac function or patient outcomes?
authors.affiliation: University of Oklahoma Health Sciences Center, Department of Family and Preventive Medicine, Oklahoma City, OK, USA.
authors.forename: Thang
authors.initials: T
authors.lastname: Nguyen
authors.forename: Robert
authors.initials: R
authors.lastname: Valentine
authors.forename: James
authors.initials: J
authors.lastname: Brand
authors.forename: Toney L
authors.initials: TL
authors.lastname: Welborn
mesh_terms: D000328:Adult; D006321:Heart / Q000503:physiopathology*; D054143:Heart Failure, Systolic / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D013318:Stroke Volume; D016896:Treatment Outcome; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014451:Ubiquinone; C024989:coenzyme Q10